FCM
ACLX

Fieldview Capital Management’s Arcellx ACLX Stock Holding History

Fieldview Capital Management’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,237
Closed -$555K – 394
2024
Q4 		$555K Buy
+7,237
New +$625K 0.09% 268

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Fieldview Capital Management's ACLX Position: Q1 2025 in Review

Fieldview Capital Management sold out of Arcellx (ACLX) in Q1 2025, closing a stake of 7,237 shares — an estimated $555K sold.

Fieldview Capital Management first reported a position in ACLX in Q4 2024 and held it in 1 quarter. The position peaked at $555K in Q4 2024. 197 funds tracked by Wall St. Rank hold ACLX as of Q1 2025.

  • Fieldview Capital Management reported no remaining Arcellx position as of Q1 2025 after selling out during the quarter.
  • Fieldview Capital Management sold 7,237 Arcellx shares in Q1 2025, an estimated $555K.
  • Fieldview Capital Management first reported a position in Arcellx in Q4 2024 and held it in 1 quarter.
  • Fieldview Capital Management's Arcellx position peaked at $555K in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Arcellx as of Q1 2025.

Based on Fieldview Capital Management's 13F filing for Q1 2025, filed 15 May 2025.